| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.027 | 0.6 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |